echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > CHMP: Positive evaluation of postoperative pain in exPAREL (Bubicain liposome suspension).

    CHMP: Positive evaluation of postoperative pain in exPAREL (Bubicain liposome suspension).

    • Last Update: 2020-10-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical company Pacira BioSciences announced today that the European Medicines Agency's (EMA) Human Medicines Commission (CHMP) has a positive opinion on the treatment of postoperative pain in EXPAREL (Bubicain liposome suspension).
    EXPAREL (Bubicain liposome suspension) blocks the plexus of the arms between the oblique muscles and is suitable for local analgesics in adults after surgery.
    , CEO and Chairman of Pacira BioSciences, said, "CHMP's positive evaluation is an important milestone in innovative non-opioid pain management.
    CHMP has made extensive recommendations for EXPAREL in various surgical environments and drug-giving techniques.
    we look forward to the EMA's final decision and hope to have the opportunity to bring safe and effective alternatives to opioids to surgical patients in Europe."
    bupivacaine is a local anaesthetic for aminoline.
    AstraZeneca sells under several product names, including Marcain, Marcaine, Sensorcaine and Vivacaine.
    is injected into surrounding tissue to block part of the nerve or injected into the spinal hole for epidural anesthesia.
    have a ready-made dosage form mixed with epinephrine to achieve long-lasting effects;
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.